SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-008463
Filing Date
2019-05-14
Accepted
2019-05-13 18:41:34
Documents
43
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0319_bisoncapital.htm 10-Q 256409
2 CERTIFICATION f10q0319ex31-1_bison.htm EX-31.1 10401
3 CERTIFICATION f10q0319ex31-2_bison.htm EX-31.2 10533
4 CERTIFICATION f10q0319ex32-1_bison.htm EX-32.1 5179
5 CERTIFICATION f10q0319ex32-2_bison.htm EX-32.2 5065
  Complete submission text file 0001213900-19-008463.txt   1399656

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bcacu-20190331.xml EX-101.INS 147121
7 XBRL SCHEMA FILE bcacu-20190331.xsd EX-101.SCH 23440
8 XBRL CALCULATION FILE bcacu-20190331_cal.xml EX-101.CAL 26551
9 XBRL DEFINITION FILE bcacu-20190331_def.xml EX-101.DEF 64500
10 XBRL LABEL FILE bcacu-20190331_lab.xml EX-101.LAB 140974
11 XBRL PRESENTATION FILE bcacu-20190331_pre.xml EX-101.PRE 113799
Mailing Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016
Business Address 609-610 21ST CENTURY TOWER 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT BEIJING F4 100016 9493506999
Bison Capital Acquisition Corp. (Filer) CIK: 0001697805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38120 | Film No.: 19820000
SIC: 2834 Pharmaceutical Preparations